Metabolomics studies revealed accelerated glycolysis of RA sero-treated HUVEC, leading to ATP accumulation but not affecting GTP levels, a process that can be inhibited by activation of SIRT1. The gene discussed is SIRT1; the disease is rheumatoid arthritis.